The IPO Buzz: 2019’s Quiet Finale

by . Posted on

This week may be the finale for the 2019 IPO market. The IPO Calendar has two small-cap deals this week. After that, there is nothing scheduled for the week of Hanukkah and Christmas and the week that follows.

But not to worry; the IPO market is merely following history. Let’s take a look at the mid- to late December traffic for the past six years, by tracking the date when the last IPO of the year started trading, based on IPOScoop data:

  • Dec. 19, 2018, was the last IPO trade date for the year.
  • Dec. 22, 2017, was the last IPO trade date for the year.
  • Dec. 16, 2016, was the last IPO trade date for the year.
  • Dec. 18, 2015, was the last IPO trade date for the year.
  • Dec. 19, 2014, was the last IPO trade date for the year.
  • Dec. 13, 2013, was the last IPO trade date for the year.

A Mid-December Duo

This week has two deals looking to raise $36.7 million: AnPac Bio-Medical Science (ANPC proposed), a $21.7 million IPO, and Indonesia Energy (INDO proposed), a $15 million IPO.

AnPac Bio-Medical Science, based in China, is a biotechnology company focusing on early cancer screening and detection. The company plans to offer 1.67 million shares at $12 to $14 each to raise $21.7 million.

Indonesia Energy, based in Jakarta, is an oil and gas exploration and production company focused on Indonesia. The company plans to offer 1.5 million shares at $9 to $11 each to raise $15 million.

 (For more information about these companies, please check the IPO Profiles on IPOScoop.com.)

December’s Fourth Week

The IPO Calendar is blank for the week of Dec. 23, 2019. Hanukkah begins at sundown on Sunday, Dec. 22nd. The U.S. stock market will close early at 1 p.m. for Christmas Eve on Tuesday, Dec. 24th. Christmas falls on Wednesday this year. Most bankers are planning to be anywhere but Wall Street during this holiday week.

Stay tuned.

Disclosure: Neither the author nor anyone else on the IPOScoop.com staff has a position in any stocks mentioned, nor do we trade or invest in IPOs. The author and IPOScoop.com staff do not issue advice, recommendations or opinions.